![]() |
JOURNAL TOOLS |
eTOC |
To subscribe |
Submit an article |
Recommend to your librarian |
ARTICLE TOOLS |
Reprints |
Permissions |

YOUR ACCOUNT
YOUR ORDERS
SHOPPING BASKET
Items: 0
Total amount: € 0,00
HOW TO ORDER
YOUR SUBSCRIPTIONS
YOUR ARTICLES
YOUR EBOOKS
COUPON
ACCESSIBILITY
CASE REPORTS Free
Minerva Anestesiologica 2008 March;74(3):93-5
Copyright © 2008 EDIZIONI MINERVA MEDICA
language: English
Treatment of severe diabetic acidosis with tris-hydroxymethyl aminomethane in a thirteen-year-old child
Marano M. 1, Iodice F. 2, Stoppa F. 1, Tomasello C. 1, Perrotta D. 1, Cecchetti C. 1, Di Nardo M. 1, Ciampalini P. 3, Pirozzi N. 1
1 DEA-Area Rossa, “Bambino Gesù” Pediatric Hospital, IRCCS, Rome, Italy; 2 PICU, “Bambino Gesù” Pediatric Hospital, IRCCS, Palidoro (RM), Italy; 3 Endocrinology Unit, “Bambino Gesù” Pediatric Hospital, IRCCS, Rome, Italy
Diabetic ketoacidosis is a severe complication of type I diabetes. A 13-year-old female (40 kg) patient was admitted to our Intensive Care Unit with severe metabolic acidosis (pH: 6.8), hyperglycemia (835 mg/dL) and coma. Her hemodynamic conditions were unstable and, even though a large amount of plasma expanders, crystalloids, and inotropic support were supplied, the patient went into cardiac arrest in the first hour of treatment. After resuscitation, a better hemodynamic balance was achieved and metabolic acidosis was treated with fluid replacement therapy, continuous insulin infusion, and Tris-hydroxymethyl aminomethane (THAM) as a buffering agent. This therapy rapidly improved her metabolic conditions. The patient was discharged 5 days after Intensive Care Unit admission in good condition and without neurological sequelae.